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ABSTRACT 
Background and Objectives: To access care, pediatric type 1 diabetes (T1D) patients living in 
British Columbia (BC), Canada, travel to the sole tertiary pediatric hospital (BC Children’s 
Hospital; BCCH), or they receive community care from pediatric endocrinologists and/or 
pediatricians. We sought to determine whether HbA1C and patient reported outcomes were 
associated with (i) distance to clinic and (ii) tertiary vs. community care. 
Methods: Patients were recruited from T1D clinics across BC. Clinical chart review and patient 
surveys were completed, including the Diabetes Treatment Satisfaction Questionnaire (DTSQ). 
Clinic type was categorized as tertiary (BCCH) or community, and travel time to BCCH was 
categorized as <1 hour (h), 1-2h, or >2h. 
Results: There were 189 participants. Age and duration of T1D were similar across groups. Mean 
number of visits/year for BCCH groups were 2.23, 2.24 and 2.05 for the <1h, 1-2h and >2h 
groups, respectively, vs. 3.26 for the community group. Adjusted mean difference in HbA1C was 
+0.65% (95% CI 0.15, 1.15) and +0.52% (95% CI 0.02, 1.02) for the BCCH >2h group 
compared to BCCH <1h group and community group, respectively. Child DTSQ scores were 
significantly lower in the BCCH >2h group compared to the BCCH <1h and community groups. 
Conclusions: Children travelling >2h to T1D clinic at BCCH had significantly higher HbA1C 
values and lower satisfaction with care versus those travelling <1h to BCCH and those receiving 
community care. Access to care closer to home may benefit glycemic control in children with 
T1D and improve treatment satisfaction. Future research should determine whether these 
findings can be replicated in other regions. 
Key Words: Diabetes mellitus, type 1; Pediatrics; Delivery of health care; Patient satisfaction; 
Health care quality, access, and evaluation 
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Introduction 
Pediatric type 1 diabetes (T1D) guidelines recommend that children receive care from a 
multidisciplinary diabetes team
1
. In British Columbia (BC), a Canadian province over 2 times 
the size of California, patients often travel long distances to attend the only tertiary T1D clinic 
located at BC Children’s Hospital (BCCH) in Vancouver, Canada. Some children receive T1D 
care in their local community via outreach by pediatric endocrinologists and/or local pediatric 
endocrinologists and pediatricians.  
 
In adults with type 2 diabetes, greater distance to care has been associated with higher 
hemoglobin A1C (HbA1C)
2,3
. A study of adult patients with T1D found no such relationship; 
however, they only included patients living in an urban center
4
. The relationship between HbA1C 
and distance to clinic has yet to be investigated in pediatric T1D and there is limited research 
comparing outcomes in children receiving community vs. tertiary care
4
. Understanding the 
impact of distance to clinic and tertiary vs. community care is critical to informing health system 
transformation for childhood diabetes. We sought to determine whether HbA1C and patient 
reported outcomes (such as adherence to treatment, satisfaction with care, and barriers to 
accessing care) were associated with (i) distance to clinic and (ii) tertiary vs. community care. 
We hypothesized that clinical outcomes and patient reported outcomes would be superior for 
children receiving care closer to home. For patients accessing care close to home, we predicted 
that clinical outcomes and patient reported outcomes would be similar, regardless of whether 
they were receiving tertiary or community care. 
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Methods 
Patients were recruited from T1D clinics across BC. Inclusion criteria included: (i) physician-
diagnosed T1D after 1-year of age and (ii) duration of T1D for 3 or more years. Patients received 
a letter of invitation in the mail prior to their clinic appointment. At their clinic appointment, 
patients who met the inclusion criteria and their parents were approached by a research assistant 
requesting participation. Aiming for an even representation of the range of patient circumstances, 
we analyzed the demographic features of the participants on a quarterly basis and used this 
information to target recruitment at specific clinics. Informed consent was obtained from all 
participants prior to the completion of surveys. At BCCH, 172 (30%) patients consented to 
participate out of 578 that were approached. This data was unavailable for community sites. 
 
Clinical data were collected by medical chart review. Patient-level data were collected through 
caregiver surveys, including demographic information. Participants were asked to identify 
reasons that make it difficult to attend diabetes clinic appointments (barriers to care). They were 
provided with a list of options and asked to select all statements that applied (see supplemental 
online material). Odds ratios of reporting a barrier were calculated based on the first response 
option - ‘It isn't difficult to take my child to diabetes clinic appointments.’ To validate the main 
outcome variable, if someone reported they had no barriers based on this first option but then 
went on to select a barrier from the subsequent choices, they were re-classified as having a 
barrier (n=8). Of note, there was also an opportunity to record barriers not identified on the list 
using free text. The list of barriers was devised a priori by the research team and was reviewed 
with the diabetes team at BCCH and pediatric diabetes clinicians from diabetes centres across the 
province. The survey was pilot tested with a small sample of patients to ensure the questions 
This article is protected by copyright. All rights reserved.
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were easy to understand prior to its implementation. Feedback from clinicians and patients was 
integrated.  
 
Clinic type was categorized as tertiary (BCCH) or community, based on self-reported primary 
diabetes physician. Some patients saw more than one provider for their diabetes care; however, 
their categorization was always based on their self-selected primary doctor. As reported by the 
caregivers, travel time to BCCH was categorized as: <1 hour (h), 1-2h, or >2h. The average of 
the last three HbA1C values was compared across the 3 aforementioned BCCH groups and the 
community group.  
 
Parents were asked to complete the Diabetes Treatment Satisfaction Questionnaire (DTSQ)
5
, a 
13-item survey that explores satisfaction with various aspects of diabetes treatment, current 
glycemic control, and support from the diabetes care team. Responses range from ‘very 
dissatisfied’ to ‘very satisfied’ on a scale from 0 to 65. An overall treatment satisfaction score is 
calculated as the sum of responses to 10 of the survey items, resulting in a maximum total score 
of 60. As per the scoring instructions, three of the items were not included in the total score, as 
they evaluated domains other than treatment satisfaction. Finally, families were asked to fill out 
the Adherence in Diabetes Questionnaire (ADQ)
6
. There are 4 parental versions of this survey 
with 17-19 questions, tailored to the age of the child (2-4 years or 5-18 years) and insulin 
regimen (conventional treatment or insulin pump.) The questionnaire evaluates self-perceived 
adherence to diabetes management, including insulin, diet, blood glucose monitoring, treatment 
of hypoglycemia/hyperglycemia, physical activity, and attendance at clinic appointments
6
. 
Responses ranged from ‘not at all’ (1) to ‘always’ (5). The final score is computed as the mean 
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of all the items, with a score of 5 indicating the highest level of adherence
6
. Children were also 
offered the opportunity to complete the youth versions of the DTSQ and ADQ, age-permitting. 
The DTSQ teen satisfaction score includes responses to 8 items (maximum score 48)
5
. The child 
ADQ format is similar to the parent survey, with 17-19 questions depending on insulin regimen
6
.  
 
Descriptive statistics are presented in terms of number and percentage for categorical variables, 
and mean and standard deviation (SD) for continuous variables. For the regression analysis, 
covariates were selected a-priori to control for confounding using causal inference methodology. 
Those significant at the 0.15 level in the unadjusted analyses were added to the multivariable 
regression models (linear regression for the continuous outcomes, and logistic regression for the 
binary outcome (yes/no) of reporting any barrier to attending clinic). Stata 14.2 was used for all 
the statistical analyses, and all the tests were 2-sided at 0.05 levels of significance
7
. 
The University of British Columbia Children's & Women’s Research Ethics Board approved the 
study. 
  
Results  
Table 1 summarizes patient characteristics. Among community patients, 77% (56/73) received 
care from a pediatric endocrinologist, of which 22% were seen by pediatric endocrinologists 
working at BCCH and providing community-based outreach, and the remainder by pediatric 
endocrinologists working in the community. Twenty-three percent (17/73) received care from 
pediatricians. Eighty-eight percent of the community group travelled less than one hour to see 
their diabetes care provider. Patients’ age and diabetes duration were comparable across groups 
(Table 1). As outlined in Table 1, community patients were seen in clinic more often compared 
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to tertiary patients (approximately 1 extra visit per year, on average). Insulin regimen differed 
across the groups, with more children utilizing continuous subcutaneous insulin infusions (CSII) 
in the community group. Parent and teen ADQ scores were similar across the groups.  
 
Twenty-three percent of community patients and 18%, 32%, and 45% of tertiary patients 
travelling <1h, 1-2h, and >2h, respectively, reported 1 barriers to attending clinic. Distance to 
clinic was the most common barrier, followed by time off work (Figure 1). Compared to 
community patients, tertiary patients travelling >2h had over 3 times higher odds of reporting 
barriers to attending clinic (odds ratio 3.46; 95% CI: 1.17, 10.25; adjusted for household income) 
(Table 2). There were no significant differences for the parental DTSQ scores between groups, 
after adjusting for age and household income. However, analysis of the child DTSQ scores 
showed notable differences. When compared to the tertiary <1h group, the tertiary >2h group 
had significantly lower DTSQ scores (score difference -7.24; 95% CI: -11.86, -2.63, p=0.003) 
(Table 3). Similarly, when compared to the community group, the tertiary >2h group again had 
significantly lower satisfaction (score difference -6.37; 95% CI -11.04, -1.70, p=0.008). Of note, 
there was no adjusted analysis for the child DTSQ scores, as no factors were found to be 
significant at the 0.15 level in the univariate analysis. Finally, mean HbA1C was significantly 
higher in the tertiary >2h group compared to tertiary <1h group (adjusted difference in HbA1C: 
0.65%; 7.1 mmol/mol, 95% CI: 0.15, 1.15%; 1.6, 12.6 mmol/mol, p=0.01] and community group 
(adjusted difference in HbA1C: 0.52%; 5.7 mmol/mol, 95% CI: 0.02, 1.02%; 0.2, 11.1 mmol/mol, 
p=0.04] (Table 4). 
 
Discussion 
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Despite similar patient demographics and self-reported treatment adherence, children travelling 
>2h to attend a tertiary T1D clinic had significantly higher mean HbA1C, increased perceived 
barriers to care, and lower satisfaction with treatment compared to those travelling <1h and those 
receiving care in their local community. Patients receiving community care had similar patient 
reported outcomes and HbA1C compared to those traveling <2h to access tertiary care.  
 
To our knowledge, we are the first to demonstrate the impact of travel time on pediatric type 1 
diabetes outcomes. The reason for this discrepancy in outcomes is unknown. All tertiary patients 
had 24-hour access to an on-call endocrinologist in case of emergencies, and access to nursing 
support on weekdays via email, fax and phone, regardless of their location. However, it is 
possible that the families travelling >2h to attend a tertiary diabetes clinic felt less connected to 
their care team, and thus did not utilize these services as frequently as patients residing closer to 
BCCH. Unfortunately, these healthcare encounters are often not recorded, preventing us from 
evaluating this hypothesis. Another possible explanation for the discrepancy in outcomes 
between the BCCH groups may be related to support provided by other physicians. Patients 
living outside of Vancouver and the surrounding area may have limited access to family 
physicians and pediatricians. However, this would not explain the differences in outcomes 
between the BCCH >2h group and the community group.  
 
Consistent with prior research, we found that community patients visited clinic more often than 
tertiary patients
4
. This may have contributed to the differences in HbA1C between the community 
and >2h tertiary group, yet it would not account for the differences between the <1h and >2h 
tertiary groups, as they had a similar number of visits per year. The differences cannot be 
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attributed to the use of CSII, as the BCCH 1-2 hour group had the lowest percentage of CSII 
patients and despite this, the mean HbA1C in this group was similar to the BCCH <1h and 
community groups. Furthermore, the discrepancy in outcomes is unlikely to be the result of a 
referral bias to the tertiary care center. As highlighted earlier, 77% of community patients were 
receiving care from a pediatric endocrinologist, and it is not common practice for these sub-
specialists to refer complex patients to BCCH, unless they are in need of other sub-specialty 
services. In addition to distance to care, there may be unknown confounders that could help to 
explain this discrepancy in outcomes for children traveling longer to access diabetes care. 
Further research focusing on patient-reported outcomes should explore what other factors may be 
contributing to our findings. 
 
Though the association between travel time to clinic and pediatric type 1 diabetes outcomes has 
not been previously explored, other investigators have compared the outcomes for patients seen 
at tertiary care centers and those seen in outreach clinics. In Australia, Joshi et al. found that 
HbA1C was similar in both groups, as were rates of diabetic ketoacidosis
8
. Another Australian 
study investigated the same issue, and also found comparable HbA1C values over a 6 year period 
in the tertiary and outreach patients
4
. In their model of care, outreach was provided by a pediatric 
endocrinologist who worked with the local diabetes care team, including a nurse educator and 
dietitian
4
. Cameron et al. compared glycemic control for patients seen in a tertiary center 
compared to regional clinics
9
. The median HbA1C values were higher in the regional clinics; 
however, the differences were not statistically significant, likely related to the small sample sizes 
at the regional clinics (n=13-18). Different from our study, the regional patients were primarily 
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managed by general practitioners and pediatricians
9
. Satisfaction with care was not formally 
assessed in the aforementioned studies. 
 
One of the major strengths of this study was our use of patient-reported travel time rather than 
distance to clinic. This is particularly important in BC, as our geography is highly variable. 
Another strength was our ability to incorporate caregiver perspectives on barriers to care. 
Limitations included our smaller sample size for the groups traveling 1-2h and >2h to BCCH. 
We also recognize that the HbA1C results were run on different assays. However, all labs in BC 
conform to the National Glycohemoglobin Standardization Program guidelines
10
. Finally, 
patients were not involved in the development of the list of barriers, a further limitation of this 
study. 
 
Conclusion 
Our findings suggest that T1D patients traveling long distances to clinic would benefit from care 
closer to home. Community care has the potential to improve glycemic control, reduce barriers to 
accessing medical services, and enhance satisfaction with care. This information can be used to 
re-evaluate current policies related to T1D models of care. With these results, decision-makers 
can advocate for resources to expand outreach efforts and enhance local capacity to deliver T1D 
care, bolstering providers ability to deliver high quality, community-based care. Further research 
should explore whether these findings can be replicated in other geographic and health system 
contexts and why care closer to home is associated with better HbA1C and satisfaction with care. 
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Table 1: Patient and family characteristics by community and tertiary hospital, stratified by travel 
time to the tertiary hospital 
Characteristics BCCH <1h 
(n=71) 
BCCH 1-2h 
(n=25) 
BCCH >2h 
(n=20) 
Community 
(n=73) 
Age (years); mean (SD) 12.13 (3.81) 12.04 (3.79) 12.50 (3.15) 12.70 (3.3) 
Male; N (%) 40 (56) 14 (56) 7 (35) 33 (45) 
Person completing survey; N (%)     
Mother/step or foster mother 56 (79) 18 (72) 19 (95) 56 (77) 
Father/step or foster father 9 (13) 4 (16) 1 (5) 13 (18) 
Other/no response 6 (8) 3 (12) 0 (0) 4 (5) 
Caucasian; N (%) 53 (75) 19 (76) 19 (95) 61 (84) 
T1D duration (years); mean (SD) 6.24 (3.49) 5.96 (2.82) 5.40 (3.02) 5.53 (3.05) 
T1D visits/year; mean (SD) 2.23 (0.75) 2.24 (0.70) 2.05 (0.76) 3.26 (0.97) 
Parental Education; N (%) M F M F M F M F 
≤ High school 8 (11) 15 (21) 5 (20) 5 (20) 0 (0) 4 (20) 15 (21) 19 (26) 
Post-secondary certificate 12 (17) 11 (15) 7 (28) 7 (28) 10 (50) 5 (25) 23 (32) 19 (26) 
College/university 29 (41) 22 (31) 6 (24) 7 (28) 5 (25) 5 (25) 19 (26) 16 (22) 
Professional degree 22 (31) 23 (32) 6 (24) 6 (24) 5 (25) 5 (25) 15 (21) 12 (16) 
Unknown 0 (0) 0 (0) 1 (4) 0 (0) 0 (0) 1 (5) 1 (1) 7 (10) 
Household Income; N (%)     
<$70,000 15 (21) 8 (32) 7 (35) 24 (33) 
$70,000-$99,999 17 (24) 5 (20) 3 (15) 16 (22) 
>$100,000 33 (46) 10 (40) 9 (45) 27 (37) 
Unknown 6 (8) 2 (8) 1 (5) 6 (8) 
Insulin regimen; N (%)     
Injections 2-3x/day 15 (21) 10 (40) 7 (35) 4 (5) 
MDI 12 (17) 4 (16) 3 (15) 9 (12) 
CSII 44 (62) 11 (44) 10 (50) 60 (82) 
ADQ Score     
Parent; mean (SD) 3.92 (0.76) 4.09 (0.59) 3.98 (0.72) 3.92 (0.69) 
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Child; mean (SD)* 4.20 (0.45) 3.91 (0.63) 4.04 (0.59) 4.19 (0.49) 
DTSQ Score     
Parent; mean (SD) 46.41 (6.14) 44.88 (11.19) 42.50 (7.86) 45.11 (8.42) 
Child; mean (SD)** 39.80 (5.86) 39.89 (6.83) 32.56 (7.47) 38.93 (5.60) 
HbA1c; mean (SD)     
% 7.88 (1.01) 8.16 (1.13) 8.64 (1.18) 8.15 (0.86) 
mmol/mol 63 (11.0) 66 (12.4) 71 (12.9) 66 (9.4) 
ADQ: Adherence in Diabetes Questionnaire; BCCH: British Columbia Children’s Hospital; 
CSII: continuous subcutaneous insulin infusion; DTSQ: Diabetes Treatment Satisfaction 
Questionnaire; F: father; M: mother; MDI = multiple daily injections; SD: standard deviation; 
T1D = type 1 diabetes 
*Sample size: BCCH <1h, n=40; BCCH 1-2h, n=15; BCCH >2h, n=15; community, n=40 
**Sample size: BCCH <1h, n=30; BCCH 1-2h, n=9; BCCH >2h, n=9; community, n=27 
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Table 2: Adjusted odds ratio of reporting barriers to accessing care comparing tertiary groups 
(BCCH; stratified by travel time) and community group from multivariate logistic regression 
 
Unadjusted odds ratio 
(95% CI) 
p-value 
Adjusted odds ratio 
(95% CI)* 
p-value 
Reference: BCCH <1h    
BCCH 1-2h 2.10 (0.75, 5.90) 0.16 1.46 (0.47, 4.53) 0.51 
BCCH >2h 3.65 (1.26, 10.61) 0.02 3.74 (1.24, 11.31) 0.02 
Community 1.35 (0.60, 3.04) 0.46  1.08 (0.45, 2.58) 0.86 
Reference: Community    
BCCH <1h 0.74 (0.33, 1.66) 0.46 0.93 (0.39, 2.21) 0.86 
BCCH 1-2h 1.55 (0.57, 4.22) 0.39 1.35 (0.45, 4.10) 0.60 
BCCH >2h 2.70 (0.96, 7.59) 0.06 3.46 (1.17, 10.25) 0.03 
*Adjusted for parental income 
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Table 3: Differences in parent and child diabetes treatment satisfaction scores between tertiary 
groups (BCCH; stratified by travel time) and community group from linear regression models 
(scores from the Diabetes Treatment Satisfaction Questionnaire) 
 
 Parent Score 
Unadjusted 
difference (95% 
CI) 
p-
value 
Parent Score 
Adjusted 
difference 
(95% CI)* 
p-
value 
Child Score 
Unadjusted** 
difference (95% 
CI) 
p-
value 
Reference: BCCH <1h   
BCCH 1-2h -1.53 (-5.21, 2.15) 0.41 -2.13 (-5.80, 1.55) 0.25 0.09 (-4.52, 4.70) 0.97 
BCCH >2h -3.91 (-7.92, 0.10) 0.06 -3.58 (-7.53, 0.37) 0.08 -7.24 (-11.86, -2.63) 0.003 
Community -1.30 (-3.94, 1.34) 0.33 -0.47 (-3.13, 2.19) 0.73 -0.87 (-4.09, 2.35) 0.59 
Reference: Community   
BCCH <1h 1.30 (-1.34, 3.94) 0.33 0.47 (-2.19, 3.13) 0.73 0.87 (-2.35, 4.09) 0.59 
BCCH 1-2h -0.23 (-3.90, 3.44) 0.90 -1.65 (-5.30, 1.99) 0.37 0.96 (-3.71, 5.63) 0.68 
BCCH >2h -2.61 (-6.61, 1.39) 0.20 -3.10 (-7.03, 0.82) 0.12 -6.37 (-11.04, -1.70) 0.008 
*Adjusted for age and income. 
** The model was not adjusted for any other variables because no other variables were 
significant at a-priori cut-off of 0.15 levels of significance in the unadjusted analysis to be 
eligible for the adjusted analysis. 
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Table 4: Group differences in mean HbA1C (%; mmol/mol) between tertiary groups (BCCH; 
stratified by travel time) and community group from linear regression models 
 Unadjusted difference  
%; mmol/mol (95% CI) 
p-value 
Adjusted difference 
%; mmol/mol (95% CI)* 
p-value 
Reference: BCCH <1h 
BCCH 1-2h 0.28; 3.1 (-0.18, 0.73; -2.0, 8.0) 0.23 0.25; 2.7 (-0.20, 0.71; 2.2, 7.8) 0.27 
BCCH >2h 0.76; 8.3 (0.26, 1.25; 2.8, 13.7) 0.003 0.65; 7.1 (0.15, 1.15; 1.6, 12.6) 0.01 
Community 0.27; 3.0 (-0.06, 0.59; -0.7, 6.4) 0.11 0.13; 1.4 (-0.21, 0.46; -2.3, 5.0) 0.46 
Reference: Community 
BCCH <1h -0.27; -3.0 (-0.59, 0.06; -6.4, 0.7) 0.11 -0.13; 1.4 (-0.46, 0.21; 5.0, 2.3) 0.46 
BCCH 1-2h 0.01; 0.1 (-0.44, 0.47; -0.48, 5.1) 0.96 0.13; 1.4 (-0.33, 0.59; -3.6, 6.4) 0.58 
BCCH >2h 0.49; 5.4 (-0.00, 0.98; -0.0, 10.7) 0.05 0.52; 5.7 (0.02, 1.02; 0.2, 11.1) 0.04 
*Adjusted for age and parental education 
BCCH: British Columbia Children’s Hospital; h = hour 
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LEGEND: 
 
Figure 1: Differences in caregiver reported barriers to care between tertiary groups (BCCH; 
stratified by travel time) and community group 
  
 
This article is protected by copyright. All rights reserved.
Fo
x 
D
A
, I
sl
am
 N
, A
m
ed
 S
. P
ed
ia
tri
c 
D
ia
be
te
s. 
20
18
. D
O
I:1
0.
11
11
/p
ed
i.1
27
49
 L
in
k:
 h
ttp
s:
//d
oi
.o
rg
/1
0.
11
11
/p
ed
i.1
27
49
Fox DA, Islam N, Amed S. Pediatric Diabetes. 2018. DOI:10.1111/pedi.12749 
Supplemental Material 
 
Barriers to Care Survey Question 
 
What are some of the reasons that make it difficult for you to take your child to his/her diabetes clinic 
appointments? (select all that apply) 
 
☐ The clinic is too far from where I live 
☐ There is no close public transportation close to where I live 
☐ I can’t afford the transportation costs 
☐ Parking at the clinic is too expensive 
☐ I work long hours and don’t have time to take my child to his/her appointments 
☐ I can’t take the time off work to take my child to his/her diabetes clinic appointment 
☐ I feel the diabetes clinic appointment isn’t a good use of my time 
☐ It’s hard to find someone to watch my other children when I take my child to his/her appointments 
☐  Other (please specify) 
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